Guided Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 150.6% | 150.6% | -129.0% |
| FY2023 | 91.7% | 91.7% | -209.0% |
| FY2024 | 49.4% | 49.4% | -175.4% |
| FY2025 | 53.2% | 53.2% | -241.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 150.6% | 150.6% | -129.0% |
| FY2023 | 91.7% | 91.7% | -209.0% |
| FY2024 | 49.4% | 49.4% | -175.4% |
| FY2025 | 53.2% | 53.2% | -241.4% |